Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chest pain sensitivity provoked by intravenous bolus adenosine in refractory angina (substudy)
2006-000540-98Phase 2Active
- Sponsor
- Karolinska University Hospital
- Start
- Feb 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of adenosine in angina pectoris (2 arms), sponsored by Karolinska University Hospital. Primary endpoint: Change in chest pain sensitivity. Started Feb 2006; status: active.
02
Drugs
adenosine
03
Conditions
angina pectoris
Beyond the preview
Go deeper on 2006-000540-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000540-98.